Literature DB >> 33262920

Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver Transplantation.

Vijayadershan Muppidi1, Sreenath Meegada2, James D Eason3, Satheesh P Nair3, Rajanshu Verma4.   

Abstract

Hilar cholangiocarcinoma, also known as Klatskin tumor, is the most common type of cholangiocarcinoma. It usually has a lymphatic spread and is rarely associated with an umbilical nodule, also known as Sister Mary Joseph nodule. We report a case of a 53-year-old Caucasian man with hilar cholangiocarcinoma. The patient had an inoperable tumor and was referred to our center for liver transplantation. Post liver transplantation, the patient presented with a recurrence of the carcinoma in the umbilical region. The patient was found to have Sister Mary Joseph nodule. It carries a poor prognosis, and our patient succumbed to the illness in four months. Cholangiocarcinoma carries a poor prognosis. Surgical resection and liver transplantation with neoadjuvant chemoradiation are the preferred treatment strategies. Association of cholangiocarcinoma with umbilical metastasis is rare, and our patient had an even rarer presentation in the form of recurrence with umbilical nodule post-liver transplantation. We want to increase the awareness of the rare presentation, association, and recurrence of hilar cholangiocarcinoma in the form of umbilical nodule post-liver transplantation.
Copyright © 2020, Muppidi et al.

Entities:  

Keywords:  liver transplantation; recurrent cholangiocarcinoma; sister mary joseph nodule; smj nodule

Year:  2020        PMID: 33262920      PMCID: PMC7689875          DOI: 10.7759/cureus.11673

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Authors:  G KLATSKIN
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

Review 2.  Liver transplantation for cholangiocarcinoma.

Authors:  Jason J Schwartz; William R Hutson; Timothy J Gayowski; John B Sorensen
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

Review 3.  Liver transplantation for hilar cholangiocarcinoma.

Authors:  Ricardo Robles; Francisco Sánchez-Bueno; Pablo Ramírez; Roberto Brusadin; Pascual Parrilla
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.

Authors:  David J Rea; Julie K Heimbach; Charles B Rosen; Michael G Haddock; Steven R Alberts; Walter K Kremers; Gregory J Gores; David M Nagorney
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 5.  Epidemiology of cholangiocarcinoma.

Authors:  Annika Bergquist; Erik von Seth
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-02-16       Impact factor: 3.043

6.  Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.

Authors:  Johnny C Hong; Henrik Petrowsky; Fady M Kaldas; Douglas G Farmer; Francisco A Durazo; Richard S Finn; Sammy Saab; Steven-Huy Han; Percy Lee; Daniela Markovic; Charles Lassman; Jonathan R Hiatt; Ronald W Busuttil
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

Review 7.  Current therapy of hilar cholangiocarcinoma.

Authors:  Stephanie Hiu Yan Lau; Wan Yee Lau
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2012-02

8.  Umbilical metastatic deposit from recurrent cholangiocarcinoma: F18-FDG PET-CT findings.

Authors:  M L Tan; A K Padhy
Journal:  Singapore Med J       Date:  2011-11       Impact factor: 1.858

9.  Liver transplantation for hilar cholangiocarcinoma.

Authors:  Armin Thelen; Peter Neuhaus
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-09-28

Review 10.  The role of liver transplantation for hilar cholangiocarcinoma.

Authors:  Durgatosh Pandey; Kang-Hoe Lee; Kai-Chah Tan
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.